|
| |
| | | 52535 | | 25.08.1994 | | Novartis Pharma Schweiz AG | | 15.09.2004 | | | | | | | | | | | 01.12. | | | | 01.12. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Lioresal intrathecal 0,05 mg/1 mL | Ampullen | (Baclofenum 50 µg/ml) | M03BX01 | PI | | 02 | Lioresal intrathecal 10 mg/5 mL | Ampullen | (Baclofenum 10mg / 5ml) | M03BX01 | PI | | 03 | Lioresal intrathecal 10 mg/20 mL | Ampullen | (Baclofenum 10mg / 20ml) | M03BX01 | PI |
|
|
|
